What does STOP-2 tell us about management of hypertension?

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study Dr Jack R W Brownrigg,

Volume 352, Issue 9131, Pages (September 1998)

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.

Volume 78, Issue 3, Pages (September 2008)

The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis Dr Michael Roerecke, PhD, Prof Janusz Kaczorowski,

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies The Emerging.

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials Sripal Bangalore, MD, MHA, Bora Toklu,

DOI: /j.atherosclerosis

Thank God for Richard Dawkins?

Long-term effects of hormone replacement therapy

Modest salt restriction in older people

The electronic future of scientific articles

Mental illness and mental health

The Systolic Blood Pressure Difference Between Arms and Cardiovascular Disease in the Framingham Heart Study Ido Weinberg, Philimon Gona, Christopher.

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

At high risk: becoming a mother in the Peruvian Andes

Low-level laser therapy for neck pain

Long-term effects of hormone replacement therapy

Underestimate of annual malaria imports to Canada – Author reply

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies The Emerging.

Expanding perception through the disordered brain

Drug therapy for coronary heart disease: the Sheffield table

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Age-specific relevance of usual blood pressure to vascular mortality

Statins for prevention of stroke

INSIGHT and NORDIL The Lancet

Volume 382, Issue 9906, Pages (November 2013)

Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta- Analysis of Randomized Trials Sripal Bangalore, MD, MHA, Bora Toklu,

A next-generation Alzheimer's centre for Madrid

Disease and stigma The Lancet Volume 354, (December 1999)

Meta-analysis of randomised controlled trials

HIV myths should not be resuscitated

When Guidelines Cause Hypertension

Volume 352, Pages S15-S18 (October 1998)

PATHWAY-2: spironolactone for resistant hypertension – Authors' reply

Bruce Neal, Fiona Turnbull The Lancet

Modest salt restriction in older people

Confessions of a journal junkie

Environmental exposure to lead: old myths never die – Authors' reply

Volume 371, Issue 9627, Pages (May 2008)

Telling it like it isn't: truth and lies in a post-9/11 world

Volume 377, Issue 9771, Pages (March 2011)

Volume 350, Issue 9087, (November 1997)

Thank God for Richard Dawkins?

Seeking asylum, losing hope

Low-technology approaches

Volume 375, Issue 9719, Pages (March 2010)

Epidemiology of stroke

The future of medical journals in the western world

ACST: which subgroups will benefit most from carotid endarterectomy?

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies The Emerging.

Prescription for change

Volume 17, Issue 2, Pages (February 1950)

MATCH Results: Implications for the Internist

Meta-analysis: is moving the goal post the answer?

Spatial lifecourse epidemiology

A remarkable report card on progress in COPD

Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits? Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,

Difficulties of surgery in the developing world: a personal view

Volume 366, Issue 9491, Pages (September 2005)

Volume 370, Issue 9602, Pages (December 2007)

Volume 1, Issue 2, Pages (July 2014)

Tapestry of life The Lancet Volume 375, Issue 9723, (April 2010)

Volume 4, Issue 1, Pages 2-3 (February 2006)

Refining treatment choices for ADHD

The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis Dr Michael Roerecke, PhD, Prof Janusz Kaczorowski,

Volume 349, Issue 9062, Pages (May 1997)

Volume 375, Issue 9713, (February 2010)

Autism, maths, and sex: the special triangle

Presentation transcript:

What does STOP-2 tell us about management of hypertension? Morris J Brown The Lancet Volume 355, Issue 9204, Pages 653-654 (February 2000) DOI: 10.1016/S0140-6736(05)72390-4 Copyright © 2000 Elsevier Ltd Terms and Conditions

Absolute vs relative risks of myocardial infarction (MI) and stroke (CVA) Data from refs 2 and 3 used to illustrate how myocardial infarction appears to be a commoner complication of hypertension than stroke because its incidence is higher in most of the blood-pressure distribution. However, stroke has a higher relative risk (plotted here as 40% vs 25% for each 6 mm Hg increase in blood pressure), and overtakes myocardial infarction as an absolute risk in severe hypertension. The Lancet 2000 355, 653-654DOI: (10.1016/S0140-6736(05)72390-4) Copyright © 2000 Elsevier Ltd Terms and Conditions